Condition: UTUC · Sponsor: Carmel Medical Center
The goal of this study is to evaluate the safety and oncological outcomes of single chemotherapy bladder instillation following endoscopic treatment for UTUC in UTUC suspected patients .The main aim is to determine the efficacy of a single, post URS, chemotherapy bladder instillation to reduce IVR. Participants will be given single chemotherapy bladder instillation within 24h following ureteroscopy and will follow routine follow-up for IVR which will include white light cystoscopy ;patients with suspected IVR (based on either imaging or cystoscopy) will undergo TURBT.
This description comes directly from the study's public registry record.
Yuval Freifeld, Dr · +972-4-8250843 · yuvalfr@clalit.org.il
Always discuss trial participation with your own doctor first.
| Assuta Ashdod Hospital | Ashdod, Israel | Recruiting |
| Soroka University Medical Center | Beersheba, Israel | Recruiting |
| Shamir Medical Center | Be’er Ya‘aqov, Israel | Recruiting |
| Bnai Zion Medical Center | Haifa, Israel | Recruiting |
| Carmel Medical Center | Haifa, Israel | Recruiting |
| Rambam Health Care Campus | Haifa, Israel | Recruiting |
| Rabin Medical Center - Beilinson and Hasharon | Petah Tikva, Israel | Recruiting |
| Kaplan Medical Center | Rehovot, Israel | Recruiting |
| Ziv Medical Center | Safed, Israel | Recruiting |
| Tel Aviv Sourasky Medical Center - Ichilov | Tel Aviv, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06167057